Hydrocortisone acetate CAS 50-03-3
Introduction：Basic information about Hydrocortisone acetate CAS 50-03-3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Hydrocortisone acetate Basic informationAdrenocorticotropic hormone drugs Indications Contraindications Adverse Reactions Precautions Chemical Property Uses Production methods
| Product Name: | Hydrocortisone acetate |
| Synonyms: | (11beta)-21-(Acetoxy)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione;11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl acetate;11-beta,17-alpha-dihydroxy-21-acetoxypregesterone;11beta17alpha-Dihydroxy-21-acetoxypregesterone;17-alpha-hydrocorticosterone21-acetate;17alpha-Hydrocorticosterone-21-acetate;Cortisone Acetate EP Impurity A（Hydrocortisone Acetate）;Hydrocortisone Impurity 3（Hydrocortisone EP Impurity C） |
| CAS: | 50-03-3 |
| MF: | C23H32O6 |
| MW: | 404.5 |
| EINECS: | 200-004-4 |
| Product Categories: | Adrenal cortical hormone drugs;API;Intermediates & Fine Chemicals;Pharmaceuticals;Biochemistry;Hydroxyketosteroids;Steroids;Hormone Drugs;Steroid and Hormone;Veterinaries;50-03-3 |
| Mol File: | 50-03-3.mol |
Hydrocortisone acetate Chemical Properties
| Melting point | 223 °C (dec.)(lit.) |
| alpha | D25 +166° (c = 0.4 in dioxane); D25 +150.7° (c = 0.5 in acetone) |
| Boiling point | 446.1°C (rough estimate) |
| density | d420 1.289 |
| refractive index | 1.4593 (estimate) |
| Fp | 223°C |
| storage temp. | 0-6°C |
| solubility | Practically insoluble in water, slightly soluble in anhydrous ethanol and in methylene chloride |
| pka | 12.42±0.70(Predicted) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | Insoluble in water. |
| Decomposition | 223 ºC |
| Merck | 14,4787 |
| BRN | 2066841 |
| Stability: | Stable, but may be light or moisture sensitive. Incompatible with strong oxidizing agents. |
| Cosmetics Ingredients Functions | SKIN CONDITIONING |
| InChIKey | ALEXXDVDDISNDU-JZYPGELDSA-N |
| SMILES | [H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]4(C)[C@@]2([H])CC[C@]4(O)C(=O)COC(C)=O |
| LogP | 2.190 |
| CAS DataBase Reference | 50-03-3(CAS DataBase Reference) |
| NIST Chemistry Reference | Hydrocortisone acetate(50-03-3) |
Safety Information
| Hazard Codes | Xn,T |
| Risk Statements | 63-10-45 |
| Safety Statements | 36/37-45-53 |
| WGK Germany | 3 |
| RTECS | GM8960000 |
| HS Code | 29372100 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
| Hazard Classifications | Repr. 1B STOT RE 2 |
| Toxicity | LD50 intraperitoneal in mouse: 2300mg/kg |
| Adrenocorticotropic hormone drugs | Hydrocortisone acetate is an adrenal hormone drugs, white crystalline powder, odorless, bitter taste. The melting point is 216~222 ℃, right optical. Slightly soluble in ethanol, ether, chloroform, acetone, insoluble in water. It was synthesized by In 17α-hydroxy progesterone. Hydrocortisone acetate has important physiological activities such as anti-inflammatory, anti-viral, anti-allergic, anti-shock, reducing inflammatory exudation effect, commonly used in clinical adrenal insufficiency and autoimmune diseases. Preparations are injection, tablets, ointments and eye drops. Adding a small amount of hydrocortisone acetate in some cosmetics cortisol can increase the efficacy of anti-allergy and improve the degree of whitening of the skin, but long-term using of such substances can cause the skin produce hormone-dependent disease. Our cosmetics cosmetics specifications prescribedthathormone substances can not be added. |
| Indications | For allergic, non-infectious skin diseases and a number of proliferative skin disorders. Such as dermatitis, eczema, neurodermatitis, seborrheic dermatitis and itching psychosis. Figure 1 the chemical structure formula of tetra-fluoroethane. |
| Contraindications | 1. This medicine and matrix components allergy and allergic to other glucocorticoids are prohibited. 2. The primary bacterial, fungal and viral infectious skin diseases such as disabledare prohibited. The above information is edited by the chemicalbook of KuiMing. |
| Adverse Reactions | Long-term using can cause local skin atrophy, telangiectasia, pigmentation, folliculitis, perioral dermatitis and secondary infection. |
| Precautions | 1. Not long-term, large-scale use. 2. The coated parts such as a burning sensation, itching, swelling, etc., should stop the medication. |
| Chemical Property | White or almost white crystalline powder, odorless. Mp218-221.5 ℃; 25D + 166 ° (dioxane) Specific rotation [α]; ethanol maximum absorption at 240nm wavelength. Insoluble in water, slightly soluble in ethanol (1: 230) and chloroform (1: 150), insoluble in ether. |
| Uses | Corticosteroid drugs, have anti-inflammatory, anti-allergic, anti-toxins, anti-shock effect. |
| Production methods | Hydrocortisone and acetic anhydride in pyridine esterification. |
| Chemical Properties | white powder |
| Uses | Glucocorticoid |
| Uses | Hydrocortisone acetate is used to treat hemorrhoids and itching/swelling in the rectum and anus. It is used to treat certain intestinal problems (such as ulcerative colitis of the rectum and other rectal/anal inflammatory conditions). |
| Definition | ChEBI: Cortisol 21-acetate is a tertiary alpha-hydroxy ketone and a cortisol ester. |
| Brand name | CortefAcetate (Pharmacia & Upjohn); Cortifoam (SchwarzPharma); Cortril (Pfizer); Dricort (Ingram); Hydrocortone(Merck). |
| Clinical Use | Corticosteroid: Local inflammation of joints and soft tissue |
| Drug interactions | Potentially hazardous interactions with other drugs Aldesleukin: avoid concomitant use. Antibacterials: metabolism accelerated by rifampicin;metabolism possibly inhibited by erythromycin;concentration of isoniazid possibly reduced. Anticoagulants: efficacy of coumarins andphenindione may be altered. Antiepileptics: metabolism accelerated bycarbamazepine, phenobarbital, fosphenytoin,phenytoin and primidone. Antifungals: increased risk of hypokalaemia withamphotericin - avoid; metabolism possibly inhibitedby itraconazole and ketoconazole. Antivirals: concentration possibly increased byritonavir. Ciclosporin: rare reports of convulsions in patientson ciclosporin and high-dose corticosteroids . Cobicistat: concentration of hydrocortisone possiblyincreased - increased risk of adrenal suppression. Diuretics: enhanced hypokalaemic effects ofacetazolamide, loop diuretics and thiazide diuretics. Vaccines: high dose corticosteroids can impairimmune response to vaccines - avoid concomitantuse with live vaccines. |
| Metabolism | Hydrocortisone is metabolised in the liver and mostbody tissues to hydrogenated and degraded forms such astetrahydrocortisone and tetrahydrocortisol.These are excreted in the urine, mainly conjugated asglucuronides, with a very small proportion of unchangedhydrocortisone. |
| Purification Methods | The acetate recrystallises from Me2CO/Et2O or aqueous Me2CO as hygroscopic monoclinic crystals. UV has max at 242 nm (A1cm 1% 390) in MeOH. Its solubility at 25o is: H2O (0.001%), EtOH (0.45%), MeOH (0.04%), Me2CO (1.1%), CHCl3 (0.5%), Et2O (0.15%), and it is very soluble in Me2NCHO. [Wendler et al. J Am Chem Soc 74 3630 1952; Antonucci et al. J Org Chem 18 7081 1953, Beilstein 8 IV 3424.] |
| Toxics Screening Level | The ITSL for hydrocortisone acetate was detennlued to be 0.04 μg/m3 with an annual averaging. |
Hydrocortisone acetate Preparation Products And Raw materials
| Raw materials | Pyridine-->Hydrocortisone-->Saponin |
| Preparation Products | Pregn-4-ene-3,20-dione, 2,11,17,21-tetrahydroxy-, (2α,11β)- (9CI)-->6-Dehydrocortisol Acetate |
